Interim open-label study results suggest higher dapivirine vaginal ring use, lower HIV risk
March 2018
Click to view Media / News Article
Full Info:
Resource Type:
Citation:
IPM. (2018, March 6). Medical Express.
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- Contraceptives
- IVR
- MPTs
Topic(s):
- MPTs
- Development
URL of resource:
https://medicalxpress.com/news/2018-03-interim-open-label-results-higher-dapivirine.html